US reclassifies medical marijuana as less-dangerous Schedule III drug
The US Department of Justice has reclassified state-licensed medical marijuana from Schedule I to Schedule III, marking a significant shift in federal drug policy.This change was announced on April 23, 2026, by Acting Attorney General Todd Blanche under the Trump administration.The reclassification moves medical marijuana from the most restrictive category, Schedule I, reserved for drugs with no accepted medical use and high potential for abuse, to Schedule III, which includes substances with a lower potential for abuse and recognized medical applications.This adjustment does not legalize marijuana federally but changes its regulatory status.The move eases research barriers by allowing scientists to... [Continue Reading]
360LiveNews | 23 Apr 2026 14:03 LONDON
